Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Rate of Endometrial Adenocarcinoma in Women Screened Before and After Implementation of the Bethesda 2001 Reporting System

Rate of Endometrial Adenocarcinoma in Women Screened Before and After Implementation of the... ACTA CYTOLOGICA GYNECOLOGIC CYTOPATHOLOGY The Journal of Clinical Cytology and Cytopathology Rate of Endometrial Adenocarcinoma in Women Screened Before and After Implementation of the Bethesda 2001 Reporting System Michael Thrall, M.D., Klint Kjeldahl, C.T.(ASCP), Kay Savik, M.S., H. Evin Gulbahce, M.D., and Stefan E. Pambuccian, M.D. Objective Results To assess the impact of the recommendation of the 2001 Benign endometrial cells were reported for 589 women in Bethesda System to report all benign-appearing endometri- the 3 years before Bethesda 2001 and for 3,810 women in al cells seen in women aged ≥ 40 years on the frequency with the 3 following years. The number of endometrial malig- which endometrial carcinomas nancies found on follow-up in are potentially detected as a these women decreased from 8 consequence of Pap test reports Our data indicate that the in the 3 years before Bethesda that mention endometrial 2001 to only 4 subsequently. Bethesda 2001 recommendations cells. The frequency of reporting have not had the desired effect, atypical or malignant glandu- Study Design lar cells, as well as the likeli- though the reason remains a We identified all women diag- hood of finding endometrial matter of speculation. nosed with endometrial adeno- malignancy on http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Cytologica Karger

Rate of Endometrial Adenocarcinoma in Women Screened Before and After Implementation of the Bethesda 2001 Reporting System

Loading next page...
 
/lp/karger/rate-of-endometrial-adenocarcinoma-in-women-screened-before-and-after-NlZGFXQHi1

References (13)

Publisher
Karger
Copyright
© 2011 S. Karger AG, Basel
ISSN
0001-5547
eISSN
1938-2650
DOI
10.1159/000325450
Publisher site
See Article on Publisher Site

Abstract

ACTA CYTOLOGICA GYNECOLOGIC CYTOPATHOLOGY The Journal of Clinical Cytology and Cytopathology Rate of Endometrial Adenocarcinoma in Women Screened Before and After Implementation of the Bethesda 2001 Reporting System Michael Thrall, M.D., Klint Kjeldahl, C.T.(ASCP), Kay Savik, M.S., H. Evin Gulbahce, M.D., and Stefan E. Pambuccian, M.D. Objective Results To assess the impact of the recommendation of the 2001 Benign endometrial cells were reported for 589 women in Bethesda System to report all benign-appearing endometri- the 3 years before Bethesda 2001 and for 3,810 women in al cells seen in women aged ≥ 40 years on the frequency with the 3 following years. The number of endometrial malig- which endometrial carcinomas nancies found on follow-up in are potentially detected as a these women decreased from 8 consequence of Pap test reports Our data indicate that the in the 3 years before Bethesda that mention endometrial 2001 to only 4 subsequently. Bethesda 2001 recommendations cells. The frequency of reporting have not had the desired effect, atypical or malignant glandu- Study Design lar cells, as well as the likeli- though the reason remains a We identified all women diag- hood of finding endometrial matter of speculation. nosed with endometrial adeno- malignancy on

Journal

Acta CytologicaKarger

Published: Jan 1, 2011

There are no references for this article.